comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 10:48:33 - browse：8

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： A controversial new treatment promises to make little people taller

explore

WSS

Medicare Advantage overpayments discussion gets experts fired up

Pharma showers House GOP doctor with campaign cash

At JPM 2024, hospital systems pitch financial strength to investors

A preacher's new calling: Diversifying neuroscience research

Gene therapy denied for Afghan refugee whose father aided U.S.

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

knowledge

comprehensive

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Stories you might have missed in 2023: health, science, medicine

How to save PrEP access — and even expand it

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Virginia high school admissions case could be legal follow

Medicare Advantage coverage denials need scrutiny, senators say

State Dept. review finds Biden bears some blame for Afghanistan failures

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Sports medicine is finally prioritizing gender equality

The cancer stories no one wants to hear

focus

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

CDC recommends RSV monoclonal antibody for infants

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Male doctors called my cancer incurable. A female doctor showed it wasn't

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Does Paxlovid work in people vaccinated against Covid

hotspot

focus

explore

focus